Uphebrin Tablets (Propiverine Hydrochloride)

Adult dose

Adults: The usual dose is 20 mg of propiverine hydrochloride orally once daily after a meal. The dose may be adjusted according to symptoms. If the effect is insufficient and there are no safety concerns, the dose may be increased to 20 mg twice daily.

This medicine should not be used in certain patients. It is contraindicated in patients with allergies to this medication or its components, gastrointestinal obstruction or deteriorated gastrointestinal function, difficulty in urination, angle-closure glaucoma, myasthenia gravis, serious heart disease, toxic megacolon or ulcerative colitis, moderate to severe liver dysfunction, and a history of arrhythmia. Additionally, it should be used with caution in patients with urinary difficulties or liver and kidney dysfunction, Parkinson's disease, hyperthyroidism, elderly patients, autonomic neuropathy, coronary artery disease, congestive heart failure, tachycardia, benign prostatic hyperplasia, cerebral sclerosis, gastroesophageal reflux disease, and glaucoma. This medication can cause various adverse reactions in the central nervous system, digestive system, circulatory system, blood, urinary system, skin, eyes, liver, and musculoskeletal system, so if any symptoms appear, treatment should be stopped immediately, and a doctor should be consulted. During treatment, patients should check for diseases that exhibit similar symptoms such as bladder cancer, prostate cancer, urinary tract infections, urinary stones, and tumors, and those with lower urinary tract obstruction should treat that condition first. The medication may cause drowsiness, dizziness, and accommodation disorders, so driving or operating hazardous machinery should be avoided. Caution should be exercised when taken with anticholinergics, tricyclic antidepressants, phenothiazine drugs, and MAO inhibitors. It is advisable not to administer this medication to pregnant women or those who might become pregnant, breastfeeding women, and children, and elderly patients should start at a lower dose considering liver and kidney function decline. In case of overdose, symptoms such as mental confusion, seizures, gait disturbance, paralytic ileus, urinary retention, and cardiac abnormalities may occur, necessitating immediate emergency treatment. This medication should be kept out of reach of children, and transferring it to other containers should be avoided to prevent accidents and degradation of quality.

• Hallucinations
• Delirium
• Paralytic Ileus
• Severe Constipation
• Abdominal Distension
• Palpitations
• Ectopic Beats
• Bradycardia
• QT Prolongation
• Ventricular Tachycardia

This medication should be stored in a tightly closed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle